Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2018, Article ID 1435746, 10 pages
https://doi.org/10.1155/2018/1435746
Review Article

Direct Cardiac Reprogramming: Progress and Promise

1Molecular, Cellular and Integrative Physiology Graduate Program, University of California, Los Angeles, CA 90095, USA
2Division of Cardiology, Department of Internal Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA
3Eli and Edythe Broad Stem Cell Research Center, University of California, Los Angeles, CA 90095, USA

Correspondence should be addressed to Reza Ardehali; ude.alcu.tendem@ilahedrAR

Received 1 September 2017; Revised 15 December 2017; Accepted 9 January 2018; Published 13 March 2018

Academic Editor: Fatemeh Sharifpanah

Copyright © 2018 James L. Engel and Reza Ardehali. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Braunwald, “The war against heart failure: the Lancet lecture,” The Lancet, vol. 385, no. 9970, pp. 812–824, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. P. A. Heidenreich, N. M. Albert, L. A. Allen et al., “Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association,” Circulation: Heart Failure, vol. 6, no. 3, pp. 606–619, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. T. J. Cahill, R. P. Choudhury, and P. R. Riley, “Heart regeneration and repair after myocardial infarction: translational opportunities for novel therapeutics,” Nature Reviews Drug Discovery, vol. 16, no. 10, pp. 699–717, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. C. J. Taylor, A. K. Roalfe, R. Iles, and F. D. Hobbs, “Ten-year prognosis of heart failure in the community: follow-up data from the Echocardiographic Heart of England Screening (ECHOES) study,” European Journal of Heart Failure, vol. 14, no. 2, pp. 176–184, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. R. L. Davis, H. Weintraub, and A. B. Lassar, “Expression of a single transfected cDNA converts fibroblasts to myoblasts,” Cell, vol. 51, no. 6, pp. 987–1000, 1987. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Choi, M. L. Costa, C. S. Mermelstein, C. Chagas, S. Holtzer, and H. Holtzer, “MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 20, pp. 7988–7992, 1990. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Vierbuchen, A. Ostermeier, Z. P. Pang, Y. Kokubu, T. C. Südhof, and M. Wernig, “Direct conversion of fibroblasts to functional neurons by defined factors,” Nature, vol. 463, no. 7284, pp. 1035–1041, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Yu, Z. Y. He, P. You et al., “Reprogramming fibroblasts into bipotential hepatic stem cells by defined factors,” Cell Stem Cell, vol. 13, no. 3, pp. 328–340, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Huang, Z. He, S. Ji et al., “Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors,” Nature, vol. 475, no. 7356, pp. 386–389, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Xie, M. Ye, R. Feng, and T. Graf, “Stepwise reprogramming of B cells into macrophages,” Cell, vol. 117, no. 5, pp. 663–676, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Ieda, J. D. Fu, P. Delgado-Olguin et al., “Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors,” Cell, vol. 142, no. 3, pp. 375–386, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Hiroi, S. Kudoh, K. Monzen et al., “Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation,” Nature Genetics, vol. 28, no. 3, pp. 276–280, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Perrino and H. A. Rockman, “GATA4 and the two sides of gene expression reprogramming,” Circulation Research, vol. 98, no. 6, pp. 715-716, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Dodou, M. P. Verzi, J. P. Anderson, S. M. Xu, and B. L. Black, “Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development,” Development, vol. 131, no. 16, pp. 3931–3942, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. S. Dai, P. Cserjesi, B. E. Markham, and J. D. Molkentin, “The transcription factors GATA4 and dHAND physically interact to synergistically activate cardiac gene expression through a p300-dependent mechanism,” Journal of Biological Chemistry, vol. 277, no. 27, pp. 24390–24398, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. J. Nam, C. Lubczyk, M. Bhakta et al., “Induction of diverse cardiac cell types by reprogramming fibroblasts with cardiac transcription factors,” Development, vol. 141, no. 22, pp. 4267–4278, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Hirai, N. Katoku-Kikyo, S. A. Keirstead, and N. Kikyo, “Accelerated direct reprogramming of fibroblasts into cardiomyocyte-like cells with the MyoD transactivation domain,” Cardiovascular Research, vol. 100, no. 1, pp. 105–113, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. R. C. Addis, J. L. Ifkovits, F. Pinto et al., “Optimization of direct fibroblast reprogramming to cardiomyocytes using calcium activity as a functional measure of success,” Journal of Molecular and Cellular Cardiology, vol. 60, pp. 97–106, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Protze, S. Khattak, C. Poulet, D. Lindemann, E. M. Tanaka, and U. Ravens, “A new approach to transcription factor screening for reprogramming of fibroblasts to cardiomyocyte-like cells,” Journal of Molecular and Cellular Cardiology, vol. 53, no. 3, pp. 323–332, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Christoforou, M. Chellappan, A. F. Adler et al., “Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming,” PLoS One, vol. 8, no. 5, article e63577, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. J. F. Islas, Y. Liu, K. C. Weng et al., “Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 32, pp. 13016–13021, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Wada, N. Muraoka, K. Inagawa et al., “Induction of human cardiomyocyte-like cells from fibroblasts by defined factors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 31, pp. 12667–12672, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. J. D. Fu, N. R. Stone, L. Liu et al., “Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state,” Stem Cell Reports, vol. 1, no. 3, pp. 235–247, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Ao, J. Hao, C. R. Hopkins, and C. C. Hong, “DMH1, a novel BMP small molecule inhibitor, increases cardiomyocyte progenitors and promotes cardiac differentiation in mouse embryonic stem cells,” PLoS One, vol. 7, no. 7, article e41627, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Cai, R. M. Guzzo, K. Wei, E. Willems, H. Davidovics, and M. Mercola, “A nodal-to-TGFβ cascade exerts biphasic control over cardiopoiesis,” Circulation Research, vol. 111, no. 7, pp. 876–881, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. J. L. Ifkovits, R. C. Addis, J. A. Epstein, and J. D. Gearhart, “Inhibition of TGFβ signaling increases direct conversion of fibroblasts to induced cardiomyocytes,” PLoS One, vol. 9, no. 2, article e89678, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. T. M. Mohamed, N. R. Stone, E. C. Berry et al., “Chemical enhancement of in vitro and in vivo direct cardiac reprogramming,” Circulation, vol. 135, no. 10, pp. 978–995, 2017. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Abad, H. Hashimoto, H. Zhou et al., “Notch inhibition enhances cardiac reprogramming by increasing MEF2C transcriptional activity,” Stem Cell Reports, vol. 8, no. 3, pp. 548–560, 2017. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Zhao, P. Londono, Y. Cao et al., “High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling,” Nature Communications, vol. 6, p. 8243, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. T. M. Jayawardena, B. Egemnazarov, E. A. Finch et al., “MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes,” Circulation Research, vol. 110, no. 11, pp. 1465–1473, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Zhou, M. E. Dickson, M. S. Kim, R. Bassel-Duby, and E. N. Olson, “Akt1/protein kinase B enhances transcriptional reprogramming of fibroblasts to functional cardiomyocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 38, pp. 11864–11869, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Yamakawa, N. Muraoka, K. Miyamoto et al., “Fibroblast growth factors and vascular endothelial growth factor promote cardiac reprogramming under defined conditions,” Stem Cell Reports, vol. 5, no. 6, pp. 1128–1142, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. P. K. Rao, Y. Toyama, H. R. Chiang et al., “Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure,” Circulation Research, vol. 105, no. 6, pp. 585–594, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Liu, S. Bezprozvannaya, A. H. Williams et al., “MicroRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart,” Genes & Development, vol. 22, no. 23, pp. 3242–3254, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Muraoka, H. Yamakawa, K. Miyamoto et al., “MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures,” The EMBO Journal, vol. 33, no. 14, pp. 1565–1581, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. T. M. Jayawardena, E. A. Finch, L. Zhang et al., “MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function,” Circulation Research, vol. 116, no. 3, pp. 418–424, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. J. Nam, K. Song, X. Luo et al., “Reprogramming of human fibroblasts toward a cardiac fate,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 14, pp. 5588–5593, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Eulalio, M. Mano, M. D. Ferro et al., “Functional screening identifies miRNAs inducing cardiac regeneration,” Nature, vol. 492, no. 7429, pp. 376–381, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. V. P. Singh, M. Mathison, V. Patel et al., “MiR-590 promotes transdifferentiation of porcine and human fibroblasts toward a cardiomyocyte-like fate by directly repressing specificity protein 1,” Journal of the American Heart Association, vol. 5, no. 11, article e003922, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Johnsson, L. Lipovich, D. Grandér, and K. V. Morris, “Evolutionary conservation of long non-coding RNAs; sequence, structure, function,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1840, no. 3, pp. 1063–1071, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. C. P. C. Gomes, H. Spencer, K. L. Ford et al., “The function and therapeutic potential of long non-coding RNAs in cardiovascular development and disease,” Molecular Theraphy Nucleic Acids, vol. 8, pp. 494–507, 2017. View at Publisher · View at Google Scholar · View at Scopus
  42. C. A. Klattenhoff, J. C. Scheuermann, L. E. Surface et al., “Braveheart, a long noncoding RNA required for cardiovascular lineage commitment,” Cell, vol. 152, no. 3, pp. 570–583, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. Z. Xue, S. Hennelly, B. Doyle et al., “A G-rich motif in the lncRNA Braveheart interacts with a zinc-finger transcription factor to specify the cardiovascular lineage,” Molecular Cell, vol. 64, no. 1, pp. 37–50, 2016. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Grote, L. Wittler, D. Hendrix et al., “The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse,” Developmental Cell, vol. 24, no. 2, pp. 206–214, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. Z. Wang, X. J. Zhang, Y. X. Ji et al., “The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy,” Nature Medicine, vol. 22, no. 10, pp. 1131–1139, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. Z. Wang and Y. Wang, “Dawn of the epi-LncRNAs: new path from Myheart,” Circulation Research, vol. 116, no. 2, pp. 235-236, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. Z. Liu, O. Chen, M. Zheng et al., “Re-patterning of H3K27me3, H3K4me3 and DNA methylation during fibroblast conversion into induced cardiomyocytes,” Stem Cell Research, vol. 16, no. 2, pp. 507–518, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. Y. Zhou, L. Wang, H. R. Vaseghi et al., “Bmi1 is a key epigenetic barrier to direct cardiac reprogramming,” Cell Stem Cell, vol. 18, no. 3, pp. 382–395, 2016. View at Publisher · View at Google Scholar · View at Scopus
  49. Z. Liu, L. Wang, J. D. Welch et al., “Single-cell transcriptomics reconstructs fate conversion from fibroblast to cardiomyocyte,” Nature, vol. 551, no. 7678, pp. 100–104, 2017. View at Publisher · View at Google Scholar · View at Scopus
  50. P. A. Lalit, M. R. Salick, D. O. Nelson et al., “Lineage reprogramming of fibroblasts into proliferative induced cardiac progenitor cells by defined factors,” Cell Stem Cell, vol. 18, no. 3, pp. 354–367, 2016. View at Publisher · View at Google Scholar · View at Scopus
  51. P. A. Lalit, A. M. Rodriguez, K. M. Downs, and T. J. Kamp, “Generation of multipotent induced cardiac progenitor cells from mouse fibroblasts and potency testing in ex vivo mouse embryos,” Nature Protocols, vol. 12, no. 5, pp. 1029–1054, 2017. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. Zhang, N. Cao, Y. Huang et al., “Expandable cardiovascular progenitor cells reprogrammed from fibroblasts,” Cell Stem Cell, vol. 18, no. 3, pp. 368–381, 2016. View at Publisher · View at Google Scholar · View at Scopus
  53. K. Song, Y. J. Nam, X. Luo et al., “Heart repair by reprogramming non-myocytes with cardiac transcription factors,” Nature, vol. 485, no. 7400, pp. 599–604, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Qian, Y. Huang, C. I. Spencer et al., “In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes,” Nature, vol. 485, no. 7400, pp. 593–598, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Ma, L. Wang, C. Yin, J. Liu, and L. Qian, “In vivo cardiac reprogramming using an optimal single polycistronic construct,” Cardiovascular Research, vol. 108, no. 2, pp. 217–219, 2015. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Mathison, V. P. Singh, R. P. Gersch et al., ““Triplet” polycistronic vectors encoding Gata4, Mef2c, and Tbx5 enhances postinfarct ventricular functional improvement compared with singlet vectors,” The Journal of Thoracic and Cardiovascular Surgery, vol. 148, no. 4, pp. 1656–1664.e2, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. L. Wang, Z. Liu, C. Yin et al., “Stoichiometry of Gata4, Mef2c, and Tbx5 influences the efficiency and quality of induced cardiac myocyte reprogramming,” Circulation Research, vol. 116, no. 2, pp. 237–244, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. S. R. Ali, S. Ranjbarvaziri, M. Talkhabi et al., “Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation,” Circulation Research, vol. 115, no. 7, pp. 625–635, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. T. C. Umei, H. Yamakawa, N. Muraoka et al., “Single-construct polycistronic doxycycline-inducible vectors improve direct cardiac reprogramming and can be used to identify the critical timing of transgene expression,” International Journal of Molecular Sciences, vol. 18, no. 8, 2017. View at Publisher · View at Google Scholar · View at Scopus
  60. Y. Fu, C. Huang, X. Xu et al., “Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails,” Cell Research, vol. 25, no. 9, pp. 1013–1024, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. N. Cao, Y. Huang, J. Zheng et al., “Conversion of human fibroblasts into functional cardiomyocytes by small molecules,” Science, vol. 352, no. 6290, pp. 1216–1220, 2016. View at Publisher · View at Google Scholar · View at Scopus
  62. L. Warren, P. D. Manos, T. Ahfeldt et al., “Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA,” Cell Stem Cell, vol. 7, no. 5, pp. 618–630, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. R. C. Addis and J. A. Epstein, “Induced regeneration--the progress and promise of direct reprogramming for heart repair,” Nature Medicine, vol. 19, no. 7, pp. 829–836, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. J. X. Chen, M. Krane, M. A. Deutsch et al., “Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5,” Circulation Research, vol. 111, no. 1, pp. 50–55, 2012. View at Publisher · View at Google Scholar · View at Scopus